- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Governor Peter Shumlin signed a bill today that would license multiple medical cannabis distribution facilities in Vermont. Patients and advocates wildly applauded the governor’s action for two main reasons:
- It recognizes the need for patients to have health care options, including the ability to safely and legally obtain their medication; and
- It defies recent attempts by the federal government to harass and intimidate public officials to prevent them from properly addressing patients’ needs.
[T]he [DOJ] will carefully consider legal remedies against those who facilitate or operate marijuana dispensaries or marijuana distribution or production as contemplated by S. 17, should that measure become law.
We need more elected officials like those in Vermont, who won’t buckle to federal bullying and who are willing to stand up for the health and welfare of patients. Notably, Delaware took similarly decisive action last month, when it passed the 16th state medical marijuana law, which includes provisions for production and distribution.
However, this type of leadership is far too rare today. We can’t give elected officials any reason to controvert science and the will of the people. We must hold them accountable at the same time as commending Shumlin and others who are willing to take a stand for patients.